JP2021518357A5 - - Google Patents

Info

Publication number
JP2021518357A5
JP2021518357A5 JP2020549620A JP2020549620A JP2021518357A5 JP 2021518357 A5 JP2021518357 A5 JP 2021518357A5 JP 2020549620 A JP2020549620 A JP 2020549620A JP 2020549620 A JP2020549620 A JP 2020549620A JP 2021518357 A5 JP2021518357 A5 JP 2021518357A5
Authority
JP
Japan
Prior art keywords
peptide
sequence
seq
item
items
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2020549620A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021518357A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/022630 external-priority patent/WO2019178573A1/en
Publication of JP2021518357A publication Critical patent/JP2021518357A/ja
Publication of JP2021518357A5 publication Critical patent/JP2021518357A5/ja
Priority to JP2023203841A priority Critical patent/JP2024015145A/ja
Ceased legal-status Critical Current

Links

JP2020549620A 2018-03-16 2019-03-15 欠失した軟骨ホーミングペプチド、及び、ペプチド複合体、及び、それらの使用方法 Ceased JP2021518357A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023203841A JP2024015145A (ja) 2018-03-16 2023-12-01 欠失した軟骨ホーミングペプチド、及び、ペプチド複合体、及び、それらの使用方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862644329P 2018-03-16 2018-03-16
US62/644,329 2018-03-16
US201862676033P 2018-05-24 2018-05-24
US62/676,033 2018-05-24
PCT/US2019/022630 WO2019178573A1 (en) 2018-03-16 2019-03-15 Truncated cartilage-homing peptides and peptide complexes and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023203841A Division JP2024015145A (ja) 2018-03-16 2023-12-01 欠失した軟骨ホーミングペプチド、及び、ペプチド複合体、及び、それらの使用方法

Publications (2)

Publication Number Publication Date
JP2021518357A JP2021518357A (ja) 2021-08-02
JP2021518357A5 true JP2021518357A5 (cg-RX-API-DMAC7.html) 2022-03-23

Family

ID=67906952

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020549620A Ceased JP2021518357A (ja) 2018-03-16 2019-03-15 欠失した軟骨ホーミングペプチド、及び、ペプチド複合体、及び、それらの使用方法
JP2023203841A Pending JP2024015145A (ja) 2018-03-16 2023-12-01 欠失した軟骨ホーミングペプチド、及び、ペプチド複合体、及び、それらの使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023203841A Pending JP2024015145A (ja) 2018-03-16 2023-12-01 欠失した軟骨ホーミングペプチド、及び、ペプチド複合体、及び、それらの使用方法

Country Status (7)

Country Link
US (1) US20210171589A1 (cg-RX-API-DMAC7.html)
EP (1) EP3773668A4 (cg-RX-API-DMAC7.html)
JP (2) JP2021518357A (cg-RX-API-DMAC7.html)
CN (1) CN112105375A (cg-RX-API-DMAC7.html)
AU (1) AU2019233914A1 (cg-RX-API-DMAC7.html)
CA (1) CA3093588A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019178573A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4031162A1 (en) * 2019-09-20 2022-07-27 Zealand Pharma A/S Kv1.3 blockers
JP2024503480A (ja) * 2021-01-19 2024-01-25 ウィリアム マーシュ ライス ユニバーシティ ポリペプチドの骨特異的送達法
CN116206697B (zh) * 2023-01-18 2025-07-15 北京石油化工学院 共晶配体筛选方法和系统

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7592009B2 (en) * 2006-10-10 2009-09-22 Ecole Polytechnique Federale De Lausanne (Epfl) Polypeptide ligands for targeting cartilage and methods of use thereof
JP5463013B2 (ja) * 2007-06-19 2014-04-09 国立大学法人 岡山大学 軟骨マーカー
SG11201504600UA (en) * 2012-12-10 2015-07-30 Hutchinson Fred Cancer Res Methods for screening
WO2014165422A1 (en) * 2013-04-02 2014-10-09 Merck Sharp & Dohme Corp. Immunohistochemical assay for detecting expression of programmed death ligand 1 (pd-l1) in tumor tissue
WO2015075699A1 (en) * 2013-11-25 2015-05-28 Sanofi Dotam derivatives for therapeutic use
EP3250223A1 (en) * 2015-01-08 2017-12-06 University of Iowa Research Foundation Methods for the regeneration of articular cartilage in vivo
CA2994865A1 (en) * 2015-09-09 2017-03-16 Fred Hutchinson Cancer Research Center Cartilage-homing peptides
CA3005928A1 (en) * 2015-12-11 2017-06-15 Fred Hutchinson Cancer Research Center Peptides for renal therapy
WO2018049285A1 (en) * 2016-09-09 2018-03-15 Fred Hutchinson Cancer Research Center Stable peptides and methods of use thereof
CN110475565A (zh) * 2017-03-16 2019-11-19 光明之火生物科学公司 软骨归巢肽缀合物及其使用方法
WO2018232122A1 (en) * 2017-06-15 2018-12-20 Blaze Bioscience, Inc. Renal-homing peptide conjugates and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2020511459A5 (cg-RX-API-DMAC7.html)
US10653801B2 (en) Targeting peptides and methods of use
JP7012360B2 (ja) 不溶性フィブリンに対する抗体
Mease et al. PET imaging in prostate cancer: focus on prostate-specific membrane antigen
CN106573031B (zh) 双末端聚乙二醇化整合素-结合肽及其使用方法
JP2017214425A (ja) 蛍光性化合物とコンジュゲートさせたリガンドによる炎症性疾患の蛍光イメージング
JP2020079288A (ja) 悪性腫瘍標的ペプチド
CA3134420A1 (en) Methods for modulating macrophage activity
KR102701695B1 (ko) 항-dkk-1 항체를 사용하여 암을 치료하기 위한 바이오마커로서의 베타-카테닌의 용도
WO2007117467B1 (en) Use of tm-601 for the diagnosis and treatment of tumors
JP2017503763A5 (cg-RX-API-DMAC7.html)
JP2025122018A (ja) Bcl9ペプチドおよびそのバリアント
US9415122B2 (en) Methods and compositions for the detection of cancer cells
JP2024015145A (ja) 欠失した軟骨ホーミングペプチド、及び、ペプチド複合体、及び、それらの使用方法
JP2026041867A (ja) 心筋画像化において[18F]-F-AraGを使用するための方法および材料
KR102677043B1 (ko) 심부전 치료를 위한 개선된 화합물
Foss et al. PET/CT imaging of CSF1R in a mouse model of tuberculosis
CN120590505B (zh) 一种重组补体蛋白及在制备抗白血病药物中的应用
US20160296646A1 (en) Alkylphosphocholine analogs for multiple myeloma imaging and therapy
JP2011523632A (ja) 脳腫瘍にホーミングするペプチド
ES2880682T3 (es) Anticuerpos anti PSA (5A10) humanizados
US11266755B2 (en) Development and application of tumor diagnostic radioactive probe targeting folic acid receptor
WO2013184678A1 (en) Molecular probes for multimodality imaging of anionic membrane surfaces
JP2010517939A (ja) 細胞の検出のための化合物および方法
US20150352192A1 (en) Methods and compositions for treating cancer